Catalyst Wire Dossier Catalyst Wire Dossier

Liquid Embolic Agent

· MicroPort NeuroTech Co., Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Liquid Embolic Agent, covering 2026-01-02 to 2026-01-02. Get the full timeline:

Most recent: Clinical Trial Update: The Liquid Embolic Agent for the Treatment of Brain Arteriovenous Malformation [NA]

See pricing